GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareCloud Inc (NAS:CCLD) » Definitions » Float Percentage Of Total Shares Outstanding

CareCloud (CareCloud) Float Percentage Of Total Shares Outstanding : 63.05% (As of Jun. 07, 2024)


View and export this data going back to 2014. Start your Free Trial

What is CareCloud Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CareCloud's float shares is 10.16 Mil. CareCloud's total shares outstanding is 16.12 Mil. CareCloud's float percentage of total shares outstanding is 63.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CareCloud's Insider Ownership is 38.35%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CareCloud's Institutional Ownership is 7.54%.


CareCloud Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

CareCloud's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=10.16/16.12
=63.05%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CareCloud (CareCloud) Business Description

Industry
Traded in Other Exchanges
Address
7 Clyde Road, Somerset, NJ, USA, 08873
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.
Executives
Mahmud Ul Haq director, 10 percent owner, officer: Chief Executive Officer 7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence Steven Sharnak director 7393, ORANGEWOOD LANE, BOCA RATON FL 33433
Anne Busquet director 390 PARK AVE 4TH FLR, NEW YORK NY 10022
A Hadi Chaudhry officer: President 7 CLYDE ROAD, SOMERSET NJ 08873
Nathalie Grey Garcia officer: General Counsel & Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence J. Steenvoorden officer: Chief Financial Officer C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Stephen Andrew Snyder director, officer: President 7 CLYDE ROAD, SOMERSET NJ 08873
Bill Korn officer: Chief Financial Officer 61 DARREN DRIVE, BASKING RIDGE NJ 07920
John N Daly director 390 STANWICH ROAD, GREENWICH CT 06830
Kimberly J Grant officer: General Counsel & Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Cameron Munter director 295 WEST ORANGE GROVE AVE, SIERRA MADRE CA 91024
Shruti H Patel officer: Interim Corporate Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Amritpal K. Deol officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873
Norman Roth officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873
Brendan Patrick Harney officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873